Tag: Hemal Mehta Sachin Mehta Sudarshan Pharma

Sudarshan Pharma Eyes Global Growth with Proposed 9.5 Percent Stake in US-Based MedTherapy Biotechnology

up18news

Sudarshan Pharma Eyes Global Growth with Proposed 9.5% Stake in US-Based MedTherapy Biotechnology Mumbai (Maharashtra) [India], September 7: Sudarshan Pharma Industries Limited is looking to accelerate its global expansion and diversify into advanced oncology with a proposed acquisition of a 9.50% equity stake in US-based MedTherapy Biotechnology Inc. The strategic investment, approved by the company’s […]

Continue Reading

Sudarshan Pharma Industries to Acquire 9.5% Stake in US-Based MedTherapy Biotech

up18news

Mumbai (Maharashtra) [India], September 7: BSE-listed Sudarshan Pharma Industries Ltd [BSE Scrip Code: 543828, Trading Symbol: SUDARSHAN, ISIN: INE00TV01023] has announced its first major overseas biotech acquisition. In a disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company informed exchanges that its Board of Directors at its meeting held today – […]

Continue Reading